Clinical Trial Update: Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray [Phase 3]

View source ↗

Summary

Phase 3 trial updating demonstration of equivalence and early onset for a novel anti-allergic nasal spray compared to a marketed spray; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis
• Hay Fever

Snippet

Sponsor: Marinomed Biotech AG | Conditions: Allergic Rhinitis, Allergic Conjunctivitis | Phase 3 | Status: COMPLETED